<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04546386</url>
  </required_header>
  <id_info>
    <org_study_id>1003/19</org_study_id>
    <nct_id>NCT04546386</nct_id>
  </id_info>
  <brief_title>Long-term Follow up for Retinal Vascular Changes After Endoscopic Endonasal Pituitary Surgery.</brief_title>
  <official_title>Retinal Vascular Changes After Endoscopic Endonasal Pituitary Surgery During One Year's Follow up, by Optical Coherence Tomography Angiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the retinal vascular features, using optical coherence tomography&#xD;
      angiography, in patients during one year's follow up after the endoscopic endonasal surgery&#xD;
      to remove an intra-suprasellar pituitary adenoma compressing the optic nerve.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The role of the optical coherence tomography angiography to detect the changes in retinal&#xD;
      vascular networks in patients after 48 hours and 1 year from the endoscopic endonasal surgery&#xD;
      to remove an intra-suprasellar pituitary adenoma compressing the optic nerve.&#xD;
&#xD;
      The optical coherence tomography angiography allows a detailed and quantitative analysis of&#xD;
      the retinal vascular networks and to follow their changes over time.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 10, 2019</start_date>
  <completion_date type="Actual">March 25, 2020</completion_date>
  <primary_completion_date type="Actual">March 10, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Study of vessel density of the retinal vascular network in patients underwent endoscopic endonasal pituitary surgery, by optical coherence tomography angiography, during long-term follow up.</measure>
    <time_frame>one year</time_frame>
    <description>To evaluate the changes in vessel density of the retinal vascular network 48 hours and 1 year after endoscopic endonasal pituitary surgery for the removal of an intra-suprasellar pituitary adenoma compressing the optic nerve, using optical coherence tomography angiography. The parameter analyzed by optical coherence tomography angiography was the vessel density of the retinal vascular network.</description>
  </primary_outcome>
  <enrollment type="Actual">14</enrollment>
  <condition>Pituitary Adenoma</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic endonasal pituitary surgery</intervention_name>
    <description>Surgical treatment consisted of an endoscopic endonasal approach using a rigid 0-degree endoscope, 18 cm in length and 4 mm in diameter</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The partecipants were older than 45 years and they underwent long term follow up after&#xD;
        endoscopic endonasal pituitary surgery to remove pituitary adenoma.&#xD;
&#xD;
        They did not present other neurological and ophthalmological diseases&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age older than 45 years&#xD;
&#xD;
          -  diagnosis of pituitary adenoma&#xD;
&#xD;
          -  treatment-naive with endoscopic endonasal pituitary surgery&#xD;
&#xD;
          -  absence of other neurological disease&#xD;
&#xD;
          -  absence of vitreoretinal and vascular retinal diseases&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age younger than 45 years&#xD;
&#xD;
          -  No diagnosis of pituitary adenoma&#xD;
&#xD;
          -  previous treatment with endoscopic endonasal pituitary surgery&#xD;
&#xD;
          -  presence of neurological disease&#xD;
&#xD;
          -  presence of vitreretinal and vascular retinal diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Gilda Cennamo</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federico II University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Naples &quot;Federico II&quot;</name>
      <address>
        <city>Naples</city>
        <zip>80100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>September 8, 2020</study_first_submitted>
  <study_first_submitted_qc>September 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2020</study_first_posted>
  <last_update_submitted>February 1, 2021</last_update_submitted>
  <last_update_submitted_qc>February 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>Gilda Cennamo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Pituitary Neoplasms</mesh_term>
    <mesh_term>Pituitary Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

